Iovance Biotherapeutics Inc. (IOVA)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | MHR Fund Management Mark Rachesky | 28,967,103 | $79,080,191 | 6.81% | |
| 2. | Invenomic Capital Management Ali Motamed | 11,959,505 | $32,649,449 | +14% | 1.52% |
| 3. | Long Focus Capital Management John B. Helmers | 8,600,000 | $23,478,000 | -6% | 0.62% |
| 4. | Palo Alto Investors William Leland Edwards | 7,116,676 | $19,428,525 | -7% | 2.7% |
| 5. | Millennium Management Israel Englander | 6,585,532 | $17,978,502 | +50% | 0.01% |
Hedge Fund Resource Center